SAPA.F
SAP SE
FrankfurtEUREQUITY
DELAYED
Last price
190.00
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
185.00
Prev close
190.00
Day high
190.00
Day low
184.00
Volume
2
Market cap
—
P/E (TTM)
—
52W range
128.00 – 240.00
Day trading desk
Gap from prior close
+2.21%
Prior close 181.00
VWAP
190.00
0.00% from price
Relative volume
—
—
Session range
3.26%
184.00 – 190.00
Position in range
100%
Near session high
ATR (14D)
7.68
4.04% of price
Prior day high
182.00
PDH
Prior day low
181.00
PDL
Bid / ask spread
—
Quote not published
Session volume
2
Shares traded
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+5.56%
+6.7%
1M
+44.49%
+41.2%
3M
+28.38%
+26.0%
6M
+11.76%
-0.1%
YTD
-7.77%
-19.7%
1Y
-17.39%
-37.5%
3Y
+49.61%
-25.4%
5Y
+55.10%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
6 more panels on SAPA.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $36.80B | $34.18B | $31.21B | $29.52B | +7.7% |
| Operating revenue | $36.80B | $34.18B | $31.21B | $29.52B | +7.7% |
| Cost of revenue | $9.99B | $9.24B | $8.67B | $8.04B | +8.0% |
| Gross profit | $26.81B | $24.93B | $22.53B | $21.48B | +7.5% |
| Research & development | $6.63B | $6.51B | $6.32B | $6.08B | +1.8% |
| Selling, general & admin | $10.51B | $10.53B | $10.19B | $9.23B | -0.1% |
| Total operating expense | $17.19B | $17.12B | $16.52B | $15.43B | +0.4% |
| Operating income | $9.62B | $7.81B | $6.01B | $6.05B | +23.2% |
| Net interest income | -$230.00M | -$64.00M | -$311.00M | -$195.00M | -259.4% |
| Pre-tax income | $10.27B | $4.76B | $5.34B | $4.51B | +115.6% |
| Tax provision | $2.94B | $1.61B | $1.74B | $1.45B | +82.4% |
| Net income | $7.16B | $3.12B | $6.14B | $2.28B | +129.2% |
| Net income to common | $7.16B | $3.12B | $6.14B | $2.28B | +129.2% |
| Basic EPS | 6.14 | 2.68 | 5.23 | 1.96 | +129.1% |
| Diluted EPS | 6.10 | 2.65 | 5.17 | 1.95 | +130.2% |
| EBIT | $10.76B | $5.31B | $5.98B | $4.91B | +102.7% |
| EBITDA | $12.07B | $6.59B | $7.35B | $6.48B | +83.2% |
| Basic shares | 1.17B | 1.17B | 1.17B | 1.17B | 0.0% |
| Diluted shares | 1.18B | 1.18B | 1.18B | 1.18B | -0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $8.22B | $9.61B | $8.12B | $9.01B | -14.5% |
| Cash & short-term investments | $9.77B | $11.24B | $11.47B | $9.86B | -13.0% |
| Accounts receivable | $5.79B | $6.23B | $5.89B | $5.78B | -7.1% |
| Total current assets | $20.26B | $21.40B | $20.57B | $18.52B | -5.4% |
| Property, plant & equipment | $4.50B | $4.49B | $4.28B | $4.93B | +0.1% |
| Goodwill & intangibles | $31.30B | $33.97B | $31.59B | $36.91B | -7.9% |
| Total assets | $70.36B | $74.24B | $68.33B | $72.16B | -5.2% |
| Total current liabilities | $17.42B | $19.08B | $14.64B | $17.45B | -8.7% |
| Current debt | $1.60B | $3.64B | $1.14B | $3.98B | -56.1% |
| Long-term debt | $4.19B | $5.30B | $6.03B | $6.96B | -20.9% |
| Total debt | $7.48B | $10.65B | $8.79B | $13.09B | -29.8% |
| Total liabilities | $25.29B | $28.43B | $24.93B | $29.31B | -11.1% |
| Retained earnings | $47.34B | $42.91B | $42.46B | $36.42B | +10.3% |
| Shareholder equity | $44.59B | $45.44B | $43.16B | $40.19B | -1.9% |
| Working capital | $2.84B | $2.32B | $5.93B | $1.07B | +22.5% |
| Net tangible assets | $13.29B | $11.47B | $11.57B | $3.27B | +15.9% |
| Shares issued | 1.23B | 1.23B | 1.23B | 1.23B | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $7.33B | $3.15B | $3.60B | $3.07B | +132.6% |
| Depreciation & amortisation | $1.31B | $1.28B | $1.37B | $1.57B | +2.4% |
| Stock-based compensation | $1.70B | $2.38B | $2.22B | $1.43B | -28.9% |
| Change in working capital | -$664.00M | $623.00M | -$27.00M | -$143.00M | -206.6% |
| Operating cash flow | $9.16B | $5.21B | $6.25B | $5.65B | +75.8% |
| Capital expenditure | -$739.00M | -$797.00M | -$785.00M | -$877.00M | +7.3% |
| Investing cash flow | -$965.00M | -$93.00M | $1.39B | $667.00M | -937.6% |
| Share buybacks | -$1.94B | -$2.11B | -$949.00M | -$1.50B | +8.0% |
| Dividends paid | -$2.74B | -$2.56B | -$2.40B | -$2.87B | -6.9% |
| Financing cash flow | -$8.74B | -$3.96B | -$8.13B | -$6.34B | -120.8% |
| Free cash flow | $8.42B | $4.41B | $5.46B | $4.77B | +90.9% |
| End cash position | $8.22B | $9.61B | $8.12B | $9.01B | -14.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $9.88B | $9.55B | $9.68B | $9.08B | $9.03B | — | +3.4% |
| Operating revenue | $9.88B | $9.55B | $9.68B | $9.08B | $9.03B | — | +3.4% |
| Cost of revenue | $2.65B | $2.58B | $2.77B | $2.40B | $2.41B | — | +2.6% |
| Gross profit | $7.23B | $6.97B | $6.92B | $6.67B | $6.62B | — | +3.7% |
| Research & development | $1.84B | $1.70B | $1.70B | $1.64B | $1.62B | — | +8.4% |
| Selling, general & admin | $2.72B | $2.50B | $2.85B | $2.55B | $2.52B | — | +8.8% |
| Total operating expense | $4.58B | $4.22B | $4.57B | $4.20B | $4.15B | — | +8.4% |
| Operating income | $2.65B | $2.75B | $2.34B | $2.47B | $2.47B | — | -3.7% |
| Net interest income | $403.00M | -$18.00M | -$617.00M | $212.00M | $49.00M | — | +2,338.9% |
| Pre-tax income | $3.01B | $2.75B | $2.56B | $2.75B | $2.50B | — | +9.5% |
| Tax provision | $797.00M | $800.00M | $825.00M | $694.00M | $753.00M | — | -0.4% |
| Net income | $2.18B | $1.93B | $1.68B | $2.00B | $1.70B | — | +12.8% |
| Net income to common | $2.18B | $1.93B | $1.68B | $2.00B | $1.70B | — | +12.8% |
| Basic EPS | 1.89 | 1.66 | 1.58 | — | 1.45 | 1.52 | +13.9% |
| Diluted EPS | 1.88 | 1.65 | 1.57 | — | 1.44 | 1.51 | +13.9% |
| EBIT | $3.33B | $3.04B | $2.19B | $3.06B | $2.77B | — | +9.6% |
| EBITDA | $3.65B | $3.34B | $2.51B | $3.38B | $3.09B | — | +9.0% |
| Basic shares | 1.15B | 1.16B | 1.17B | — | 1.17B | 1.17B | -0.9% |
| Diluted shares | 1.16B | 1.17B | 1.17B | — | 1.18B | 1.18B | -0.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $10.51B | $9.65B | $8.22B | $8.55B | $7.94B | — | +8.9% |
| Cash & short-term investments | $11.63B | $10.04B | $9.77B | $9.93B | $10.18B | — | +15.7% |
| Accounts receivable | $7.08B | $8.57B | $5.79B | $5.78B | $5.78B | — | -17.5% |
| Total current assets | $22.65B | $22.25B | $20.26B | $18.91B | $19.64B | — | +1.8% |
| Property, plant & equipment | $4.50B | $4.48B | $4.50B | $4.40B | $4.34B | — | +0.6% |
| Goodwill & intangibles | $33.05B | $31.76B | $31.30B | $31.42B | $30.83B | — | +4.1% |
| Total assets | $75.61B | $73.46B | $70.36B | $68.40B | $68.40B | — | +2.9% |
| Total current liabilities | $19.73B | $20.82B | $17.42B | $17.11B | $19.05B | — | -5.2% |
| Current debt | — | — | $1.60B | — | $2.85B | $3.64B | — |
| Long-term debt | — | — | $4.19B | — | $4.26B | $5.30B | — |
| Total debt | $10.51B | $7.86B | $7.48B | $9.12B | $8.75B | — | +33.6% |
| Total liabilities | $30.36B | $28.10B | $25.29B | $25.16B | $27.00B | — | +8.1% |
| Retained earnings | $48.58B | $49.28B | $47.34B | $45.67B | $43.65B | — | -1.4% |
| Shareholder equity | $44.74B | $44.86B | $44.59B | $42.81B | $41.00B | — | -0.3% |
| Working capital | $2.92B | $1.44B | $2.84B | $1.80B | $588.00M | — | +103.1% |
| Net tangible assets | $11.70B | $13.10B | $13.29B | $11.39B | $10.17B | — | -10.7% |
| Shares issued | 1.15B | 1.23B | 1.23B | 1.16B | 1.23B | — | -6.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $2.21B | $1.95B | $1.73B | $2.05B | $1.75B | +13.5% |
| Depreciation & amortisation | $316.00M | $305.00M | $325.00M | $318.00M | $319.00M | +3.6% |
| Stock-based compensation | $468.00M | $285.00M | $316.00M | $430.00M | $529.00M | +64.2% |
| Change in working capital | $756.00M | $864.00M | -$804.00M | -$1.10B | -$31.00M | -12.5% |
| Operating cash flow | $3.15B | $3.51B | $1.30B | $1.50B | $2.58B | -10.2% |
| Capital expenditure | -$116.00M | -$238.00M | -$180.00M | -$201.00M | -$190.00M | +51.3% |
| Investing cash flow | -$1.74B | $822.00M | -$218.00M | -$74.00M | -$716.00M | -311.9% |
| Share buybacks | -$321.00M | -$2.28B | $0 | -$304.00M | -$1.51B | +85.9% |
| Dividends paid | -$2.88B | $0 | $0 | $0 | -$2.74B | — |
| Financing cash flow | -$511.00M | -$3.03B | -$1.30B | -$700.00M | -$5.02B | +83.2% |
| Free cash flow | $3.04B | $3.27B | $1.12B | $1.30B | $2.39B | -7.2% |
| End cash position | $10.51B | $9.65B | $8.22B | $8.55B | $7.94B | +8.9% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
181.00
+4.97% from price
SMA 20
172.78
+9.97% from price
SMA 50
151.87
+25.11% from price
SMA 100
150.81
+25.99% from price
SMA 200
170.20
+11.63% from price
EMA 12
178.64
+6.36% from price
EMA 26
168.68
+12.64% from price
EMA 50
160.44
+18.42% from price
RSI (14)
67.8
Neutral
MACD (12,26,9)
9.95
Hist 0.71
ATR (14)
7.68
4.04% of price
Realised vol 30D
61.7%
Annualised
Bollinger upper
193.45
20, 2σ
Bollinger lower
152.10
20, 2σ
50 / 200 cross
Death
151.87 vs 170.20
Trend bias
Above 200
+11.63%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.15
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
61.7%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-46.7%
Peak to trough
Max drawdown 5Y
-54.6%
Peak to trough
ATR 14
7.68
4.04% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Astellas Doses First Patient in Phase 3 Study of ASP2138 in CLDN18.2-postive and HER2-negative locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
PR Newswire · 9m ago
Vance calls Canada a 'state' during rally, says it was 'Freudian slip'
USA TODAY · 11m ago
2 Monster Stocks to Buy and Hold for the Next 20 Years
Motley Fool · 14m ago
Market Chatter: Situational Awareness Trading Activity Draws SEC Subpoenas
MT Newswires · 17m ago
Fidelity Government Money Market Fund (SPAXX): What Investors Should Know
24/7 Wall St. · 18m ago
How to Build $7,800 a Month in Dividend Income Without Owning a Single Yield Trap
24/7 Wall St. · 21m ago
Amazon’s latest price move comes with a nasty surprise
TheStreet · 22m ago
Why Zillow's FTC settlement is a clear win for the company
TheStreet · 24m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.